Rafferty Asset Management, LLC Global Blood Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $2.25 Million - $4.72 Million	-69,291 Reduced 40.36%	102,397 $6.97 Million
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $526,391 - $882,590	-23,605 Reduced 12.09%	171,688 $5.49 Million
Q1 2022 May 13, 2022	BUY	$25.68 - $35.59 $36,696 - $50,858	1,429 Added 0.74%	195,293 $6.77 Million
Q4 2021 Feb 10, 2022	BUY	$24.9 - $40.26 $1.95 Million - $3.16 Million	78,480 Added 68.02%	193,864 $5.67 Million
Q3 2021 Nov 10, 2021	BUY	$25.48 - $37.34 $1.3 Million - $1.91 Million	51,200 Added 79.77%	115,384 $2.94 Million
Q2 2021 Aug 10, 2021	SELL	$32.46 - $43.42 $373,030 - $498,982	-11,492 Reduced 15.19%	64,184 $2.25 Million
Q1 2021 May 10, 2021	BUY	$38.94 - $50.85 $2.05 Million - $2.68 Million	52,698 Added 229.34%	75,676 $3.08 Million
Q4 2020 Feb 10, 2021	SELL	$37.65 - $63.77 $550,781 - $932,891	-14,629 Reduced 38.9%	22,978 $995,000
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $1.18 Million - $1.67 Million	22,359 Added 146.64%	37,607 $2.07 Million
Q2 2020 Aug 07, 2020	BUY	$48.73 - $81.82 $450,216 - $755,934	9,239 Added 153.75%	15,248 $963,000
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $1.88 Million - $3.93 Million	-45,020 Reduced 88.22%	6,009 $307,000
Q4 2019 Feb 10, 2020	SELL	$45.7 - $81.86 $3.15 Million - $5.64 Million	-68,944 Reduced 57.47%	51,029 $4.06 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $1.29 Million - $1.64 Million	28,385 Added 30.99%	119,973 $5.82 Million
Q2 2019 Aug 09, 2019	SELL	$52.6 - $63.29 $397,708 - $478,535	-7,561 Reduced 7.63%	91,588 $4.82 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $3.96 Million - $5.3 Million	99,149 New	99,149 $5.25 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account